Shanghai Fosun Pharmaceutical(Group) Co.,Ltd.’s Net Profit Rose 75.7% in First Quarter of 2023

Shanghai Fosun Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) (600196.SH) reported a net profit of 1.1 billion yuan in the first quarter of 2023, up 75.7% year-on-year.

Meanwhile, the company posted 10.9 billion yuan in revenue, up 4.7% year-on-year.

At the end of the reporting period, it had 107.4 billion yuan in total assets and 52.3 billion yuan in total liabilities, with a liability-to-asset ratio of 48.7%.